NEW GENERATION IN DEVICE-FREE MICROGRAFT TECHNOLOGY
Unlock your own tissue’s regenerative potential without needing any device.
The graft is harvested from the sun-protected donor area behind the ear, where cells are younger and more active. It is processed through Relyzer blades in saline or PRP and, after rapid filtration, becomes ready for injection.
Relyzer Blade Technology
Relyzer 600 µm Processing
Thousands of custom-designed blades inside, process tissue fragments at a micro level and release cells together with their own microenvironment (ECM and growth factors); it is designed to preserve viability.
Relyzer 150 µm Security Filtration
The suspension is passed through the Relyzer 150 µm in a single pass; large and unwanted tissue fragments are filtered out, resulting in a homogeneous, safely injectable form.
Clinical Evidence
In a randomized controlled study (Gentile P, JPRAS Open 2026), autologous micrografts prepared with the Dermograft platform were compared with a hyaluronic acid (HA) skin booster (n=20+20, 12-month follow-up). In the study group, significant superiority was observed in wrinkle severity and skin elasticity:
DERMOGRAFT
HA SKIN BOOSTER
Increase in skin elasticity
+%27
+%5
Improvement in WSRS wringle score
1,4 Score
0,3 Score
Full satisfaction rate
%80
%55
Ref: Gentile P. Autologous Fibroblast Therapy for Facial Rejuvenation: A Randomized Open-Label Controlled Study. JPRAS Open 2026. doi:10.1016/j.jpra.2026.05.045
Cellular Content and Identity
Flow cytometry analysis conducted in the same study showed that the Dermograft suspension contained a population with high viability and a follicular/mesenchymal stem cell identity:
2,78 × 10⁶/mL
Nucleated cell concentration
%89,6
Cell Viability
CD44 %98,7
nucleated cell concentration
CD200 %80,0
nucleated cell concentration
Cytokeratin-15 %99,4
nucleated cell concentration
CD45 %0,2
nucleated cell concentration
Implementation in 3 steps
1
Graft Harvesting
A small graft is harvested from behind the ear under local anesthesia.
2
Processing
The graft is processed by passing it through the Relyzer 600 µm with saline and/or PRP.
3
Filtration and Injection
The suspension is passed through a Relyzer 150 µm in a single pass and injected.